<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03086850</url>
  </required_header>
  <id_info>
    <org_study_id>HULP-2613</org_study_id>
    <nct_id>NCT03086850</nct_id>
  </id_info>
  <brief_title>Long-term Effect of the Physical Activity Promotion on the Clinical Characteristics and Vascular Risk in Patients With Mild-moderate Obstructive Sleep Apnea</brief_title>
  <acronym>PASOS</acronym>
  <official_title>Randomized, Parallel and Controled Clinical Trial to Assess the Effect of the Physical Activity Promotion During 12 Months on the Clinical Characteristics and Vascular Risk in Patients With Mild-moderate Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main objective: To assess the effect of the daily physical activity promotion with a
      pedometer during 12 months on the apnea-hypopnea index (AHI) in patients with mild to
      moderate obstructive sleep apnea (OSA).

      Study patients. Subjects 30-80 years old with diagnosis of mild-moderate OSA (AHI: 5-30 and
      predominance of obstructive events [&gt;80%)].

      Design. Randomized, parallel and open-label clinical trial, controlled with conventional
      treatment.

      Intervention: Patients will be randomized (1:1) to control group [treatment and follow-up
      according to conventional clinical practice] or intervention group [in addition to
      conventional treatment and follow-up, the patients will receive a pedometer to measure the
      number of steps walked daily. Based on the cumulative step count for each day and the mean
      value since the last visit, patients will receive a task to increase their steps per day by
      the next appointment according to the next protocol (&lt;6000 steps/day: increase by 3000
      steps/day; 6000 - 10000 steps/day: reach 10000 steps/day; and &gt; 10000 steps/day: maintain or
      increase steps).

      Measurements. At , 12, 24 and 52 weeks of randomization, the following determinations will be
      made: anthropometric characteristics; clinical evaluation (smoking history, sleep symptoms,
      comorbidities, current medication); questionnaires (ESS, FOSQ, SF-12, EuroQoL and iPAZ);
      heart rate and blood pressure; analytical determinations (HbA1c, HOMA index, cholesterol,
      LDL-cholesterol, HDL-cholesterol, triglycerides, homocysteine, NT-proBNP and hsCRP);
      plasmatic biomarkers (8-isoprostane, IL1beta, IL6, IL8 and TNFalpha); and evaluation of daily
      physical activity using an accelerometer.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 3, 2017</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea-hypopnea index</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the apnea-hypopnea index of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nocturnal oxyhemoglobin saturation</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the nocturnal oxyhemoglobin saturation of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity level</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the physical activity level of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline determinants of physical activity</measure>
    <time_frame>12 months</time_frame>
    <description>To relate the baseline physical activity performed by patients with mild-moderate sleep apnea with their sleep parameters</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the fat free mass index of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diurnal sleepiness</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the Epworth sleepiness scale of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional impact</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the total score of the Functional Outcomes of Sleep Questionnaire of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systematic Coronary Risk Evaluation</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the Systematic Coronary Risk Evaluation of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin sensitivity</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the HOMA index of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the plasmatic 8-isoprostane levels of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic inflammation</measure>
    <time_frame>12 months</time_frame>
    <description>To compare the plasmatic levels of IL-1beta, IL6, IL8 and TNF-alpha of patients with mild-moderate obstructive sleep apnea between conventional treatment or conventional treatment plus daily physical activity promotion with a pedometer</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Pedometer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard recommendations on healthy habits and lifestyle plus daily recording of steeps with a pedometer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional management</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment and follow-up according to conventional clinical practice (SEPAR guidelines), including standard recommendations on healthy habits and lifestyle.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Promotion of daily physical activity with a pedometer</intervention_name>
    <description>Patients will receive an ONwalk 100 pedometer (GEONAUTE, France) and will be instructed how to use it. They will be encouraged to be more active by using the pedometer to measure the number of steps walked daily and to record this in a diary, together with any information related to their clinical condition. Based on the cumulative step count for each day and the mean value since the last visit, patients will receive a task to increase their steps per day by the next appointment according to the next protocol:
&lt;6000 steps/day: increase by 3000 steps/day
6000 - 10000 steps/day: reach 10000 steps/day
&gt; 10000 steps/day: maintain or increase steps</description>
    <arm_group_label>Pedometer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional treatment</intervention_name>
    <description>Treatment and follow-up according to conventional clinical practice (SEPAR guidelines), including standard recommendations on healthy habits and lifestyle.</description>
    <arm_group_label>Pedometer</arm_group_label>
    <arm_group_label>Conventional management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age from 30 to 80 years

          -  Diagnosis of mild-moderate obstructive sleep apnea [apnea-hypopnea index 5-30 h-1] by
             polysomnography or respiratory polygraphy

          -  Predominance of obstructive events (&gt; 80%)

          -  Signature of informed consent

        Exclusion Criteria:

          -  Previous diagnosis of chronic obstructive pulmonary disease, asthma, diffuse
             interstitial lung disease or chest wall disease.

          -  Evidence of central apneas, hypoventilation syndrome or respiratory failure

          -  Previous diagnosis of refractory arterial hypertension, congestive heart failure,
             ischemic heart disease or cerebro-vascular disease.

          -  Neurological or osteoarticular limitation that prevents ambulation.

          -  Professional drivers or occupational risk or respiratory

          -  Previous treatment with CPAP

          -  Participation in another clinical trial in the 30 days prior to randomization.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Francisco Garcia-Rio, MD</last_name>
    <phone>+34914269802</phone>
    <email>fgr01m@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Francisco Garcia-Rio</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Garcia-Rio, MD</last_name>
      <phone>+34914269802</phone>
      <email>fgr01m@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Isabel Fern치ndez-Navarro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bego침a S치nchez-S치nchez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raquel Casitas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2017</study_first_submitted>
  <study_first_submitted_qc>March 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <last_update_submitted>April 4, 2017</last_update_submitted>
  <last_update_submitted_qc>April 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario La Paz</investigator_affiliation>
    <investigator_full_name>Francisco Garcia-Rio</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

